Screener
Kiniksa Pharmaceuticals International, plc KNSA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other long-term assets | 10,834 | 11,307 |
| Intangible asset, net | 14,750 | 15,250 |
| Deferred tax assets | 190,965 | 198,149 |
| Total assets | $896,110 | $763,633 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $12,404 | $2,028 |
| Accrued collaboration expenses | 88,049 | 70,015 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's total assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported total assets of $896.11M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's total assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's total assets increased by 35.5% year-over-year, from $661.15M to $896.11M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's total assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's total assets has grown at a 16.9% compound annual growth rate (CAGR), from $349.46M to $763.63M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Kiniksa Pharmaceuticals International, plc's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude